CSIMarket
 
Apyx Medical Corporation  (APYX)
Other Ticker:  
 
 
Price: $1.7900 $0.10 5.917%
Day's High: $1.8 Week Perf: 2.87 %
Day's Low: $ 1.69 30 Day Perf: -26.94 %
Volume (M): 56 52 Wk High: $ 7.97
Volume (M$): $ 100 52 Wk Avg: $3.62
Open: $1.69 52 Wk Low: $1.41



 Market Capitalization (Millions $) 64
 Shares Outstanding (Millions) 36
 Employees -
 Revenues (TTM) (Millions $) 49
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 1

Apyx Medical Corporation
Apyx Medical Corporation is a leading medical technology company that specializes in developing and commercializing innovative solutions for various surgical procedures. The company is known for its flagship product called the J-Plasma system, which utilizes a unique energy system to provide controlled and precise tissue cutting, coagulation, and ablation. Apyx Medical Corporation's technology is widely used in the fields of plastic surgery, dermatology, and other surgical specialties. The company aims to improve patient outcomes and enhance surgical precision by continuously innovating and developing advanced medical devices.


   Company Address: 5115 Ulmerton Road, Clearwater 33760 FL
   Company Phone Number: 384-2323   Stock Exchange / Ticker: NASDAQ APYX
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Contract

Apyx Medical Corporation Reports Impressive Revenue Growth in Q4 and Full Year 2023

Published Mon, Jan 8 2024 12:00 PM UTC

CLEARWATER, Fla. - Apyx Medical Corporation (NASDAQ: APYX), a leading manufacturer of proprietary helium plasma and radiofrequency technology known as Renuvion, has recently announced its preliminary revenue results for the fourth quarter and full year ended December 31, 2023. The company recorded remarkable growth in both periods, demonstrating its continued success in the ...

Apyx Medical Corporation

Breaking News: APYX's Revenue Soars, Yet Profitability Eludes During Q3 2023!

Interpreting Apyx Medical Corporation's Financial Results: A Promising Future Amidst Recent Challenges
By
As an avid investor closely monitoring the financial landscape, I couldn't help but be intrigued by Apyx Medical Corporation's recent financial results. In the span ending September 30, 2023, the company reported a surge in revenue by 20.452% to $10.98 million compared to the same reporting season the previous year. While this growth is undoubtedly impressive, it is important to also consider other key factors that have contributed to Apyx Medical Corporation's current standing.
Despite the positive revenue growth, the company has faced losses amounting to $-0.13 per share. However, it is worth noting that Apyx Medical Corporation's business advanced at a much faster pace compared to its industry peers in the Medical Equipment & Supplies sector. In fact, the majority of businesses in this sector saw an average rise of only 4.89% relative to the same period a year ago. Thus, it is clear that Apyx Medical Corporation has managed to outperform its competitors, even in the face of challenges.

Stock Issue News

Empowering Innovation: Apyx Medical Secures $45 Million Credit Agreement with Perceptive Credit Holdings

Published Thu, Nov 9 2023 12:01 PM UTC



Clearwater-based Apyx Medical Corporation (NASDAQ: APYX) has recently made a significant development in securing a new five-year credit agreement with Perceptive Credit Holdings IV, LP (Perceptive), an affiliate of investment management firm Perceptive Advisors. The credit agreement is set to provide a facility of up to $45 million in senior secured term following ...

Apyx Medical Corporation

Apyx Medical Corporation Achieves Remarkable 29.023% Surge in Revenue, Demonstrating Exceptional Fiscal Performance in Q2 2023

Apyx Medical Corporation, a leading Medical Equipment & Supplies company, has shown significant improvement in its financial performance during the second quarter of 2023. The company managed to decrease its loss per share from $-0.16 to $-0.03 compared to the previous year, indicating a positive trend. Additionally, earnings per share improved from $-0.10 to a more favorable position.
One of the key highlights of Apyx Medical Corporation's performance is its impressive revenue growth. The company experienced a rapid increase of 29.023% in revenue, reaching $13.28 million in the second quarter of 2023 compared to $10.29 million in the same period a year before. Even when observing sequential revenue, Apyx Medical Corporation's revenue advanced by 9.364%, rising from $12.14 million in the previous financial reporting period. This growth has proven to be superior to its industry peers in the Medical Equipment & Supplies sector, which only witnessed a 4.48% top-line advance during the same period.

Apyx Medical Corporation

Apyx Medical Corporation's Revenue Softens in Q1 2023 - Should Investors Be Worried?

Investing in the stock market always carries with it a degree of risk, but when a company like Apyx Medical Corporation reports a cumulative net loss of $-21 million during the 12 months that ended in the first quarter of 2023, investors should be cautious. This loss resulted in a negative return on equity of -51.34%.
While Apyx Medical Corporation belongs to the Medical Equipment & Supplies industry, its return on equity is ranked lower than 83 other companies, indicating that other firms in the sector are performing better.
Although the overall ranking of Apyx Medical Corporation for its return on equity has slightly improved from the previous quarter, its latest results are not yet encouraging. For example, the company's revenue decreased by -2.81% to $12.14 million from $12.49 million in the same quarter a year ago. Sequentially, the revenue fell a further -3.719%.
However, Apyx Medical Corporation did show some improvement, as its earnings per share rose to $-0.10 per share from $-0.17 per share, and its net loss as of the most recent fiscal period decreased significantly from $-5.968 million to $-3.532 million. Still, investors should be concerned about the continuous drop in gross revenueGiven this mixed financial picture, investors need to weigh the potential benefits of investing against the risks. Apyx Medical Corporation is expected to report its next financial results on August 10, 2023, giving investors an opportunity to review the company's progress and determine whether it is an attractive investment opportunity. As always, it is wise to consult a qualified financial advisor who can guide investors through the stock market and help them make prudent investment decisions.






 

Apyx Medical's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com